0 items USD 0.00Search
Your search for "system fibrosis drug" gave back 498223 results.
Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Pipeline Review, H1 2018 Summary Lysophosphatidic Acid Receptor 1...
颁补迟补濒辞驳:听
Global Markets Direct
March 2018
Price: USD 3,500.00
The global Liver Fibrosis Drug market size was valued at US$ 11680 million in 2023. With growing demand in downstream market, the Liver Fibrosis Drug...
颁补迟补濒辞驳:听
LPI
January 2024
Price: USD 3,660.00
Liver fibrosis is the scarring process that represents the liver鈥檚 response to injury. In the same way as skin and other organs heal wounds through...
颁补迟补濒辞驳:听
MRRPB5
February 2024
Price: USD 2,900.00
The global Drugs for Retroperitoneal Fibrosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 2,900.00
The global Cutaneous Fibrosis Treatment market size was valued at US$ 558.4 million in 2023. With growing demand in downstream market, the Cutaneous...
颁补迟补濒辞驳:听
LPI
January 2024
Price: USD 3,660.00
Highlights The global Cystic Fibrosis Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
The global Idiopathic Pulmonary Fibrosis Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by...
颁补迟补濒辞驳:听
GIR
June 2024
Price: USD 3,480.00
The global Idiopathic Pulmonary Fibrosis Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Idiopathic...
颁补迟补濒辞驳:听
LPI
February 2024
Price: USD 3,660.00
Cutaneous fibrosis is the accumulation of extracellular matrix (ECM) components in the dermis, leading to compromised function and altered...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 3,950.00
Transforming Growth Factor Beta 1 (TGFB1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players,...
颁补迟补濒辞驳:听
Global Markets Direct
February 2022
Price: USD 3,500.00
The global Idiopathic Pulmonary Fibrosis Treatment Drug market was valued at US$ 336 million in 2023 and is anticipated to reach US$ 571.3 million by...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 2,900.00
The global Idiopathic Pulmonary Fibrosis Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
Liver fibrosis is the scarring process that represents the liver鈥檚 response to injury. In the same way as skin and other organs heal wounds through...
颁补迟补濒辞驳:听
GIR
September 2024
Price: USD 3,480.00
The global Idiopathic Pulmonary Fibrosis Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 4,900.00
Pulmonary fibrosis is a lung disorder characterized by damage or scarring of the lung tissue. Once the tissue is damaged, it obstructs the passageway...
颁补迟补濒辞驳:听
MRRPB5
October 2023
Price: USD 2,900.00
听
